Carl Walkey Neoleukin Therapeutics, Inc. (NLTX) insider trading activity
Carl Walkey is Senior Vice President of Neoleukin Therapeutics, Inc.. Currently has a direct ownership of 1.35 Million shares of NLTX, which is worth approximately $0. The most recent transaction as insider was on Feb 03, 2021, when has been sold 2,400 shares (Common Stock) at a price of $13.23 per share, resulting in proceeds of $31,752. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.35M
0%
3M change
0%
12M change
Total Value Held
$0
CW
Carl Walkey
Senior Vice President
Seattle, WA